Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity - Test2 - elhamkhani - TriplyDB

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

http://www.wikidata.org/entity/Q27027973

about

The biomarkers of immune dysregulation and inflammation response in Parkinson disease Emerging preclinical pharmacological targets for Parkinson's disease Splicing Regulation of Pro-Inflammatory Cytokines and Chemokines: At the Interface of the Neuroendocrine and Immune Systems p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease Redox control of microglial function: molecular mechanisms and functional significance Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-κB and Jak2-Stat3 Signaling Pathways Longitudinal changes in free-water within the substantia nigra of Parkinson's disease Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.The role of Galectin-3 in α-synuclein-induced microglial activation.Minocycline mitigates the gliogenic effects of proinflammatory cytokines on neural stem cells.Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice.Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice.Morphometric characterization of microglial phenotypes in human cerebral cortex Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system.Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.Glial epigenetics in neuroinflammation and neurodegeneration.Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.Active immunization therapies for Parkinson's disease and multiple system atrophy.Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide.Lumbee traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.Microglial phenotypes in Parkinson's disease and animal models of the disease.Knockdown of α-synuclein in cerebral cortex improves neural behavior associated with apoptotic inhibition and neurotrophin expression in spinal cord transected rats.Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine.LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments.α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide.A Novel Immunosuppressor, (5R)-5-Hydroxytriptolide, Alleviates Movement Disorder and Neuroinflammation in a 6-OHDA Hemiparkinsonian Rat Model.

P2860

Q26738459-723CBD91-DBF9-4FED-9D3D-E0EBF969966E Q26764724-E3F69257-1E3E-427E-8230-62996C00A2D9 Q26786915-533141DD-89A6-413C-8881-EAE7171421D2 Q26799375-85BE6B36-400A-4FD6-8E4B-AC398FCFD2FD Q26853537-312DD6DD-ECDB-4C2D-9BCA-60AF5E9919E2 Q27000279-25F4BA4E-E72D-49E6-AF38-D195037704C4 Q27015811-7DCA5CED-2573-44F2-9296-2831E84BD6B8 Q28550386-2147FC10-99B9-4588-8B96-76EE2F91B63A Q30952963-13DC3097-1ABB-4769-BF22-E9BF362752F2 Q33740654-C2FE1C92-A7BD-4861-B388-C80103F6EDAB Q33771694-545A369A-DAEB-4E3D-B672-967657F28275 Q34537231-C86DFD5B-0F64-44C1-B252-063B1C894899 Q34674246-5C3B5D03-0FBE-40E0-ADCC-2F3DFFDC3759 Q34675135-1344C7C4-E1FC-4E62-B667-19959687B05C Q35058359-2E107F15-46D6-4E6E-B134-B08D3FC2DD6A Q35285839-74939322-C6A9-4180-A4BE-AC5F3FB3B270 Q35587423-F355BE56-136A-47DC-8D8F-B78DDBF9873A Q36131340-D68492EA-6654-43B6-9181-C7F4BA9C962F Q36212145-637ED7F6-6D80-425F-BD5B-94B7DA7F00D4 Q36265332-0F979BC5-4F71-4A1D-B8F4-85570340080F Q37151427-21D0BD30-C024-4FC4-B442-1374B3E5F703 Q37532369-88EC1437-C776-4C06-9665-128079E762D1 Q37670608-ED5153A2-2A44-4185-9316-8882FF6CBAE6 Q38124378-D62801E4-C49F-4AC4-9627-AB2018D77E31 Q38197952-F119B7B4-4EA6-4D93-BFF6-AA8F333E5EC8 Q38322767-C021BF94-56C3-49A7-AF55-F5C2E1BC9AF6 Q38541943-14DA635B-80BF-4EA7-84AD-8CD2909C565B Q38556918-490D0DCF-F1AF-42A4-A82A-8200A9B4A114 Q38564102-93FDDC6C-F24B-4774-B071-E3316EAD66A4 Q38617000-3E9952E5-8FFA-40B5-8A7A-BE1A31FB9BAE Q38715902-F541C8E1-5A4B-4C27-9C4C-ACA3EF9F5B7D Q38766966-47697680-1570-4191-83BE-7B41B3F18F52 Q38815779-C87A7356-116B-40F6-964D-9A32BEF16395 Q38914810-C9DB6590-AE87-4E45-9557-829E92A7C6C6 Q39043765-567DC4FC-DFA7-487F-A44A-036BC005002A Q39137339-EB9B1903-3794-4981-80CD-C1AEED41429F Q39148230-8100F47B-6A21-43F3-BA75-88FCC21B11D8 Q39972820-985BB34F-E59B-462D-B5D4-8DCECD9068D5 Q40468324-03B5CF25-B568-4C4D-8011-3CBA371F4168 Q42048890-9B3D7744-9C8A-48FA-9AAF-AF2DB45CD6FD

P2860

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

http://www.wikidata.org/entity/Q27027973

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Neuroimmunological processes i ...... cesses and peripheral immunity

@ast

Neuroimmunological processes i ...... cesses and peripheral immunity

@en

Neuroimmunological processes i ...... cesses and peripheral immunity

@nl

type

label

Neuroimmunological processes i ...... cesses and peripheral immunity

@ast

Neuroimmunological processes i ...... cesses and peripheral immunity

@en

Neuroimmunological processes i ...... cesses and peripheral immunity

@nl

prefLabel

Neuroimmunological processes i ...... cesses and peripheral immunity

@ast

Neuroimmunological processes i ...... cesses and peripheral immunity

@en

Neuroimmunological processes i ...... cesses and peripheral immunity

@nl

P1433

Q27027973-5BB6708C-F821-4E2D-8C1C-20FA496804BC

P1476

Q27027973-7E5F72C0-E5AF-41BD-8BB4-77A6400AC2CD

P2093

Q27027973-4FD8E2D2-AE13-4B3E-B3CD-45E224D7B544

Q27027973-ACBCB9D1-FBC7-4078-9FF4-B4D3E414E3ED

Q27027973-C895A0E0-4810-4F61-89A5-6690497062BB

Q27027973-F23420DE-79C7-427F-BCBF-668BCC6DFD87

P275

Q27027973-86F7B199-16D4-4F4B-B93C-085E991220B4

P2860

Q27027973-01D3D36D-A1D1-4DC3-8B92-2B8AF03C21BC

Q27027973-01FA38FF-3E1E-46CD-9A19-D369B8F73F8F

Q27027973-058B3A62-8BDC-4ACF-86A0-67890EDEA2F1

Q27027973-0B037067-CB5C-4734-B48F-A53A6C5B260E

Q27027973-0B36297C-A5D8-4101-BDD1-E01A111272D6

Q27027973-0B6249BB-3D4F-4CFB-AA34-C3CEFF329DC5

Q27027973-0C9FCCEB-5C69-4097-A9F2-0CF9BB074A55

Q27027973-0D0CFE2A-FDA7-4721-BF56-B63F5D871852

Q27027973-0D3F180E-55AE-41D9-BA44-88A6CEDC7DDA

Q27027973-0D5E45B4-C2BE-404A-8C14-24274425548E

P304

Q27027973-7BAA978B-93E3-4E40-90C6-909DAFD63D0B

P31

Q27027973-459F4747-1550-4E37-B874-EA9764EB1E45

Q27027973-48A2D808-6855-4A39-A6EB-6DF270910522

P3181

Q27027973-C00BEF85-B1CC-43F8-9ED1-5161C270B9E9

P356

Q27027973-BA0F0B4A-D451-4D94-8118-0916BAC714EE

P407

Q27027973-88CE6B53-62B4-416F-AF27-2F98FB57AD33

P433

Q27027973-DD6B9569-5B5F-4D7E-B4B2-B31CBD4FBC80

P478

Q27027973-78D9D517-59BB-459F-BD2F-11A1EC3087B9

P5008

Q27027973-73467723-04C1-492E-A206-E166524D5D24

P577

Q27027973-BA075DE5-AD2E-41D3-A200-4ED751ADFDF0

P5875

Q27027973-89452E94-5B9F-4A72-BFA8-4198AF369069

P698

Q27027973-AB1C2CB4-DD22-45D1-92A3-62D069FFD4B0

P921

Q27027973-03A4D38D-AF17-419E-B434-FA39609D1D31

Q27027973-0C87518C-5551-45AC-9549-979068589637

Q27027973-131801CC-C13B-408A-9577-3FF8182BBCAD

Q27027973-AE487930-534A-4FE0-8678-2248D3A93533

Q27027973-BEA391F1-26DF-4480-B764-317AD9AE6586

Q27027973-E14690B3-83FD-4672-A0E9-649DD012B934

Q27027973-EF69E740-6F67-4F39-A36C-CAD9675ED2A1

P932

Q27027973-03100244-7B08-45CF-BB89-C0C71AAB8844

P3181

P356

P1433

P1476

Neuroimmunological processes i ...... cesses and peripheral immunity

@en

P2093

Christopher J. Barnum

http://www.w3.org/2001/XMLSchema#string

Malú G. Tansey

http://www.w3.org/2001/XMLSchema#string

Marina Romero‑Ramos

http://www.w3.org/2001/XMLSchema#string

Vanesa Sanchez‑Guajardo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Rotenone, paraquat, and Parkinson's disease

Defining "neuroinflammation" lessons from MPTP- and methamphetamine-induced neurotoxicity

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

P304

113-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2429128

http://www.w3.org/2001/XMLSchema#string

P356

10.1042/AN20120066

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236058512

http://www.w3.org/2001/XMLSchema#string

P698

23506036

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

nerve tissue proteins

Parkinson disease associated proteins

P932

3639751

http://www.w3.org/2001/XMLSchema#string